Ruff, C. T., Koren, M. J., Grimsby, J., Rosenbaum, A. I., Tu, X., Karathanasis, S. K., Falloon, J., Hsia, J., Guan, Y., Conway, J., Tsai, L., Hummer, B. T., Hirshberg, B., Kuder, J. F., Murphy, S. A., George, R. T., & Sabatine, M. S. (2021). lEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, 41(12), 3005–3014. http://access.bl.uk/ark:/81055/vdc_100146088605.0x00000d